Skip to main content

Table 1 Comparison of the general characteristics between the two groups

From: Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis

 

Treatment group (n = 29)

Control group (n = 29)

p

Age (years, mean ± standard deviation)

54.66 ± 10.24

54.83 ± 11.79

0.953

Gender [n(%)]

 Male

26

27

1.000

 Female

3

2

History of gout (years, median [range])

3 (0–10)

3 (0–11)

0.856

BMI (kg/m2, mean ± standard deviation)

26.70 ± 4.07

26.20 ± 5.00

0.678

Uric acid (umol/L, before treatment)

506.28 ± 79.88

501.12 ± 95.49

0.824

VAS score (before treatment)

8.38 ± 0.97

8.34 ± 0.97

0.876

The score for joint swelling (before treatment)

5.93 ± 1.44

5.90 ± 1.63

0.941

The score for joint tenderness (before treatment)

7.03 ± 1.84

6.93 ± 1.81

0.836

The score for joint mobility function (before treatment)

2.45 ± 0.57

2.41 ± 0.50

0.777

The score for TCM syndrome (before treatment)

19.69 ± 4.18

19.55 ± 3.81

0.894